Metraipolis › archive › dc_52ec12fd3bd2

HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability — Europe PMC PMID:40877222

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40877222
DOI
10.1038/s41420-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-10T07:09:56.497Z
SHA-256 of the archived text
1b82f16516fe298b390d858b0813255abb5d071d7d8fd0af1d23bd5f7b8c4908
Stable URL of this page
https://metraipolis.com/documento/dc_52ec12fd3bd2

How to cite

HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability — Europe PMC PMID:40877222 — Europe PMC (en), https://europepmc.org/article/MED/40877222 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52ec12fd3bd2 (Metraipolis archive dc_52ec12fd3bd2, sha256 1b82f16516fe298b390d858b0813255abb5d071d7d8fd0af1d23bd5f7b8c4908)
BibTeX
@misc{dc52ec12fd3bd2,
  title = {HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability — Europe PMC PMID:40877222},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40877222},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52ec12fd3bd2; sha256 1b82f16516fe298b390d858b0813255abb5d071d7d8fd0af1d23bd5f7b8c4908},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40877222. Agents can read the archived copy with the MCP tool read_document.